Camostat for kidney protection in chronic kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests if a drug called camostat can help protect the kidneys in people with chronic kidney disease. It also includes a group of healthy volunteers for comparison.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have chronic kidney disease with a certain level of kidney function and protein in your urine
- Your blood pressure is stable and within a certain range
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You are not taking certain medications or have certain health conditions that would make participation risky
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the drug amiloride can help slow down chronic kidney disease. It may be an option if you have moderate kidney function and high protein in your urine.
This study tests if matching treatments to your specific kidney disease markers can better protect your kidneys. It looks at how well Finerenone, Dapagliflozin, and Semaglutide work alone or in a sequence.
This study compares the effectiveness and resource use of remote patient monitoring across different dialysis methods for people with end-stage renal disease. It aims to see if remote monitoring can improve care and outcomes.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This study tests a new medicine (BI 690517) combined with empagliflozin to see if it can help protect the heart and kidneys in people with chronic kidney disease. It may slow down kidney disease progression and reduce heart risks.
This study tests whether a medicine called cilastatin can prevent kidney damage caused by certain strong medications. If you are receiving one of these medications and are at risk for kidney injury, this trial may offer protection.
Hear when a new Chronic Kidney Disease(CKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.